Dentis

261200 · KOSDAQ · ₩261200 · 덴티스

₩2,520▲ ₩5 (0.20%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about Dentis

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

Dentis is loss-making on an operating basis in H1 2026 and its shares have fallen about 52% over the past year, with a stretched debt load.

Dentis sells dental implants, LED dental lights and 3D printers in South Korea and abroad. Trailing revenue to H1 2026 is about ₩111.7B, but operating income is about -₩5.4B and free cash flow is about -₩3.8B, while borrowings of ₩99.5B sit against cash of ₩3.0B. The share price is ₩2,410, near the lower part of its 52-week range of ₩2,125 to ₩5,100.

What stands out

  • 2025 was a weak year: revenue was roughly flat at ₩114.2B, operating income swung to about -₩10.4B and net income was about -₩14.2B.
  • Trailing net income is positive at about ₩1.4B, but this is well below the operating loss, so the profit picture depends on non-operating items the data does not explain.
  • Liabilities are about 281% of equity and the company carries roughly ₩99.5B of borrowings, a high debt load relative to its cash.
  • Valuation metrics look low on a P/E of 27 and P/B of 0.7, but the earnings base is volatile and the data gives no forecasts to judge whether this reflects value.
  • Foreign ownership fell from 4.4% to 3.4% over about 60 days, and the 20-day flows show foreign buying alongside net retail selling.

What to watch

  • Whether the company returns to positive operating income in its next reported results, given the H1 2026 operating loss.
  • Filings on the disclosure-compliance designation: the company was named an unfaithful disclosure company in September 2026 and was then not designated after a deferred review in October.
  • Ongoing shareholder changes and convertible bond activity, which the recent filings show, and any effect on dilution or control.

Data as of Oct 23, 2026 · written 4d ago

This is not financial advice.

Also known as: Dentis / 덴티스 / 261200 / KRX:261200

Source: KRX statistical information